Axim Cases and Covers in the News

Mon, 18 Dec 2017 22:16:09 GMT
This RSS feed URL is deprecatedThis RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Fri, 01 Dec 2017 04:28:53 GMT
GridIron BioNutrients (MYYZ) Bioceutical Breakthrough May Hold the Key to the NFL's Deadly CTE Crisis - MMJ Observer

GridIron BioNutrients (MYYZ) Bioceutical Breakthrough May Hold the Key to the NFL's Deadly CTE Crisis
MMJ Observer
You've seen it in the news – the NFL is facing a revenue-crushing epidemic. CTE–the devastating brain disease stalking the NFL has sent dozens of companies scrambling for answers. But while the NFL tries out $1,500 helmets and neurosurgeons on the ...



Mon, 27 Nov 2017 22:44:13 GMT
This Bioceutical Breakthrough May Hold the Key to the NFL's Deadly CTE Crisis - MMJ Reporter

MMJ Reporter

This Bioceutical Breakthrough May Hold the Key to the NFL's Deadly CTE Crisis
MMJ Reporter
But while the NFL tries out $1,500 helmets and neurosurgeons on the sidelines, the surprising best answer may come from a plant. It turns out that cannabinoids, could be an even more powerful neuroprotector than scientists had previously suspected. And ...



Wed, 29 Nov 2017 14:19:24 GMT
Patents in the Cannabis Sector; A Growing Trend - InvestorIdeas.com (press release)

Patents in the Cannabis Sector; A Growing Trend
InvestorIdeas.com (press release)
The current approximately 1,500 cannabis-related US patent cases can be divided into groups: (1) compositions and preparation methods, (2) characterization of cannabinoids in terms of interaction with human cannabinoid receptors, and (3) treating ...

and more »


Wed, 06 Dec 2017 13:46:52 GMT
Advanced Biosynthesis Setting New Standards for Cannabinoid-based Pain Management $countyNameToPathMap ... - PR Newswire (press release)

Advanced Biosynthesis Setting New Standards for Cannabinoid-based Pain Management $countyNameToPathMap ...
PR Newswire (press release)
TN in particular is known for symptoms involving intense and uncontrollable face and jaw spasms, causing pain that is so severe it has been nicknamed "the suicide disease ." It is estimated that 12 new cases of TN occur per 100,000 persons every year ...

and more »


Wed, 23 Nov 2016 16:11:44 GMT
Marijuana Stocks: Short AXIM Biotechnologies...If You Can Borrow And Finance The Shares - Seeking Alpha

Marijuana Stocks: Short AXIM Biotechnologies...If You Can Borrow And Finance The Shares
Seeking Alpha
AXIM has [1] a negative working capital position, [2] toxic convertibles, and [3] a negative gross profit on meager revenues. Fidelity indicates that AXIM shares are [1] “hard to borrow” and [2] charges a 6.5% annual interest rate to maintain a short ...



Tue, 27 Jun 2017 13:32:02 GMT
AXIM Biotechnologies (OTCQB: AXIM) Takes on Opioid Epidemic with New Patent -- SECFilings.com - Marketwired (press release)

AXIM Biotechnologies (OTCQB: AXIM) Takes on Opioid Epidemic with New Patent -- SECFilings.com
Marketwired (press release)
REDONDO BEACH, CA--(Marketwired - Jun 27, 2017) - SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, announces the publication of an article covering AXIM® Biotechnologies Inc. ( OTCQB ...

and more »


Thu, 14 Sep 2017 08:04:11 GMT
Biosynthesis Technology Could Transform Cannabinoid Production - Markets Insider

Biosynthesis Technology Could Transform Cannabinoid Production
Markets Insider
... within the burgeoning sector, including Axim Biotechnologies, Inc. (OTC: AXIM), GW Pharmaceuticals (NASDAQ: GWPH), Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) and pharmaceutical heavyweight Eli Lilly and Company (NYSE: LLY). Perhaps the clearest ...

and more »


Tue, 21 Mar 2017 13:02:03 GMT
AXIM Biotech Retains Ora to Manage Upcoming Product Development and Clinical Trials on Glaucoma and Dry Eye ... - GlobeNewswire (press release)

AXIM Biotech Retains Ora to Manage Upcoming Product Development and Clinical Trials on Glaucoma and Dry Eye ...
GlobeNewswire (press release)
NEW YORK, March 21, 2017 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that it has retained the services of Ora®, Inc., a global Contract Research ...

and more »


Fri, 17 Mar 2017 14:38:29 GMT
Cannabinoid-based chewing gum enrolls patients in Ph II trial - In-PharmaTechnologist.com

In-PharmaTechnologist.com

Cannabinoid-based chewing gum enrolls patients in Ph II trial
In-PharmaTechnologist.com
“Cannabinoids and in particular CBD are well known to positively affect all of the above functions and therefore, are natural choices for the treatment in these cases​.” Forty patients were recruited based on Rome III criteria. The patients range in ...

and more »


Wed, 18 Oct 2017 12:19:13 GMT
Transenterix Inc (NYSEAMERICAN:TRXC) Reports Dismissal Of Federal Securities Class Action - Journal Transcript

Journal Transcript

Transenterix Inc (NYSEAMERICAN:TRXC) Reports Dismissal Of Federal Securities Class Action
Journal Transcript
Transenterix Inc (NYSEAMERICAN:TRXC), a medical device firm that is pioneering the application of robotics to enhance minimally invasive surgery, reported that the U.S. District Court has dismissed the securities class action case filed in June 2016 ...

and more »